Quantum Genesis AI Corp. (OTC: QGAI) issued a statement on May 19, 2026, to clarify its research activities and intellectual property ownership, addressing potential confusion surrounding previously published scientific research. The company emphasized that Quantumzyme LLP, a separate entity based in Bengaluru, India, is not a subsidiary or affiliate of Quantum Genesis AI, despite being referenced in prior press releases.
The clarification stems from earlier press releases dated November 5, 2025, and February 12, 2026, which cited scientific publications in the company's broader enzyme engineering and biocatalysis field. Those publications listed Quantumzyme LLP and reflected the affiliations of researchers at the time of submission. Quantum Genesis AI now seeks to distinguish itself from Quantumzyme LLP and provide context on intellectual property rights transferred to the company.
According to the statement, the company's CEO, Naveen Kulkarni, transferred certain intellectual property, know-how, methodologies, and research materials to Quantum Genesis AI through an Asset Purchase Agreement dated February 21, 2023. A subsequent confirmatory assignment, disclosed in the company's Form 8-K filed on April 29, 2026, further clarified the scope of intellectual property and technology rights associated with its enzyme engineering and biocatalysis platform.
The company asserts that any research activities conducted by Mr. Kulkarni, whether directly or through Quantumzyme LLP, that relate to its core enzyme engineering and biocatalysis field and are based on or derived from the transferred technology platform and intellectual property fall within the rights transferred to the company. This includes methodologies, computational approaches, and related know-how.
Quantum Genesis AI believes that its prior disclosures regarding scientific publications were made in good faith based on its ownership of the relevant intellectual property. The company's core focus is on advancing technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation, with a commitment to transparency and responsible corporate governance.
For more information, visit qgaicorp.com and the company's profile on OTC Markets.
